Search Results

Long-term efficacy and public health implications of the Vi-tetanus toxoid conjugate vaccine in Bangladeshi children.

• Authors : Al-Mamun, Firoj^1,2,3 (AUTHOR); Mamun, Mohammed A^1,2,3 (AUTHOR); Roy, Nitai⁴ (AUTHOR)

Subjects: *VACCINATION of children; *PUBLIC health

• Source: Lancet. Oct2024, Vol. 404 Issue 10461, p1378-1379. 2p.

Record details

5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial.

• Authors : Qadri, Firdausi¹ (AUTHOR) ; Khanam, Farhana¹ (AUTHOR); Zhang, Yiyuan^1,2,3 (AUTHOR)

Subjects: *VACCINE effectiveness; *SCHOOL entrance age; *BOOSTER vaccines

• Source: Lancet. Oct2024, Vol. 404 Issue 10461, p1419-1429. 11p.

Record details

Efficacy of typhoid conjugate vaccine in Malawian children.

• Authors : Obaro, Stephen¹ (AUTHOR)

Subjects: *VACCINATION of children; *TYPHOID fever

• Source: Lancet. Aug2024, Vol. 404 Issue 10454, p747-748. 2p.

Record details

Efficacy of typhoid conjugate vaccine in Malawian children – Authors' reply.

• Authors : Neuzil, Kathleen M¹ (AUTHOR) ; Patel, Priyanka D² (AUTHOR); Ndeketa, Latif² (AUTHOR)

Subjects: *VACCINATION of children; *TYPHOID fever

• Source: Lancet. Aug2024, Vol. 404 Issue 10454, p748-748. 1p.

Record details

Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.

• Authors : Ochoge, Magnus¹ (AUTHOR); Futa, Ahmed Cherno¹ (AUTHOR); Umesi, Ama¹ (AUTHOR)

Subjects: *ORAL vaccines; *INFANTS; *CLINICAL trialsGAMBIABILL & Melinda Gates Foundation BILL & Melinda Gates Foundation BILL & Melinda Gates Foundation 127256381

• Source: Lancet. Mar2024, Vol. 403 Issue 10432, p1164-1175. 12p.

Record details

Malaria vaccines for children: and now there are two.

• Authors : Moorthy, Vasee¹ (AUTHOR) ; Hamel, Mary J² (AUTHOR); Smith, Peter G³ (AUTHOR)

Subjects: *MALARIA vaccines; *VACCINATION of children

• Source: Lancet. Feb2024, Vol. 403 Issue 10426, p504-505. 2p.

Record details

The legacy of the COVID-19 pandemic for childhood vaccination in the USA.

• Authors : Opel, Douglas J^1,2 (AUTHOR) ; Brewer, Noel T^3,4 (AUTHOR); Buttenheim, Alison M^5,6 (AUTHOR)

Subjects: *VACCINATION of children; *COVID-19 pandemic

• Source: Lancet. Jan2023, Vol. 401 Issue 10370, p75-78. 4p.

Record details

COVID-19 vaccination for children aged 5-11 years.

• Authors : Ladhani, Shamez N¹ (AUTHOR)

• Source: Lancet. Jul2022, Vol. 400 Issue 10346, p74-76. 3p.

Record details

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.

• Authors : Li, Grace¹ (AUTHOR); Cappuccini, Federica^1,2 (AUTHOR); Marchevsky, Natalie G¹ (AUTHOR)

• Source: Lancet. Jun2022, Vol. 399 Issue 10342, p2212-2225. 14p.

Record details

COVID-19 vaccination in young children.

• Authors : Burki, Talha Khan

Subjects: VACCINATION of children; COVID-19 vaccines

• Source: Lancet Respiratory Medicine; Apr2022, Vol. 10 Issue 4, pe41-e41, 1p

Record details